Pliant Therapeutics (PLRX) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Pliant Therapeutics (PLRX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | 250K (-81.20%) | 1.33M (-32.49%) | 1.97M (+33.11%) | 1.48M (-70.34%) | 4.99M (+299.20%) | 1.25M (-37.50%) | 2.00M (+24.22%) | 1.61M (-10.06%) | 1.79M (-17.51%) | 2.17M (-51.45%) | 4.47M (-7.07%) | 4.81M (+33.61%) | 3.60M (-87.56%) | 29M (-49.27%) | 57M | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 14M (-12.89%) | 16M (-13.10%) | 18M (-44.29%) | 32M (-25.87%) | 43M (+11.99%) | 39M (-18.76%) | 48M (+4.67%) | 46M (+22.80%) | 37M (+11.97%) | 33M (+2.60%) | 32M (-2.00%) | 33M (+12.74%) | 29M (+16.57%) | 25M (+2.03%) | 25M (-6.57%) | 26M (+26.15%) | 21M (+11.36%) | 19M (-10.93%) | 21M (+9.52%) | 19M (+3.72%) | 19M (+3.81%) | 18M (+5.75%) | 17M (-3.76%) | 18M (+26.01%) | 14M (-40.72%) | 23M (+117.81%) | 11M (-17.71%) | 13M | - |
Selling General And Administrative | 8.19M (+2.50%) | 7.99M (-22.65%) | 10M (-22.85%) | 13M (-13.61%) | 16M (+6.68%) | 15M (+1.89%) | 14M (-5.06%) | 15M (-1.51%) | 15M (+10.11%) | 14M (-9.77%) | 15M (+5.35%) | 15M (+2.97%) | 14M (-0.70%) | 14M (+61.56%) | 8.82M (+6.27%) | 8.30M (-3.26%) | 8.58M (+9.30%) | 7.85M (+2.35%) | 7.67M (+39.96%) | 5.48M (-16.59%) | 6.57M (+16.70%) | 5.63M (+22.66%) | 4.59M (+50.99%) | 3.04M (-24.19%) | 4.01M (-29.65%) | 5.70M (+120.93%) | 2.58M (-2.27%) | 2.64M | - |
Operating Expenses | 22M (-7.68%) | 24M (-16.59%) | 28M (-37.99%) | 46M (-22.65%) | 59M (+10.54%) | 53M (-14.01%) | 62M (+2.26%) | 61M (+15.75%) | 52M (+11.37%) | 47M (-1.36%) | 48M (+0.23%) | 48M (+9.56%) | 43M (+10.31%) | 39M (+17.77%) | 33M (-3.47%) | 35M (+17.55%) | 29M (+10.75%) | 27M (-7.38%) | 29M (+16.32%) | 25M (-1.59%) | 25M (+6.86%) | 23M (+9.31%) | 21M (+4.37%) | 21M (+14.78%) | 18M (-38.55%) | 29M (+118.41%) | 13M (-15.12%) | 16M | - |
Depreciation And Amortization | 260K (-42.22%) | 450K (+12.50%) | 400K (0.00%) | 400K (-11.11%) | 450K (-11.76%) | 510K (+2.00%) | 500K (-16.67%) | 600K (+17.65%) | 510K (+4.08%) | 490K (-2.00%) | 500K (+25.00%) | 400K (-11.11%) | 450K (-4.26%) | 470K (-6.00%) | 500K (+25.00%) | 400K (-13.04%) | 460K (+21.05%) | 380K (-5.00%) | 400K (0.00%) | 400K (+11.11%) | 360K (-10.00%) | 400K (+33.33%) | 300K (0.00%) | 300K (-3.23%) | 310K (-49.18%) | 610K (+103.33%) | 300K (+50.00%) | 200K | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -21.77M (-7.68%) | -23.58M (-16.59%) | -28.27M (-37.99%) | -45.59M (-22.64%) | -58.93M (+10.52%) | -53.32M (-14.01%) | -62.01M (+2.26%) | -60.64M (+15.75%) | -52.39M (+11.37%) | -47.04M (-1.34%) | -47.68M (+0.74%) | -47.33M (+12.45%) | -42.09M (+12.54%) | -37.40M (+17.06%) | -31.95M (+7.79%) | -29.64M (+5.07%) | -28.21M (+14.67%) | -24.60M (-9.26%) | -27.11M (+18.38%) | -22.90M (-0.09%) | -22.92M (+20.50%) | -19.02M (+14.17%) | -16.66M (-1.88%) | -16.98M | 11M (-60.50%) | 28M | -13.36M (-15.12%) | -15.74M | - |
Ebit | -21.77M (-7.68%) | -23.58M (-16.59%) | -28.27M (-37.99%) | -45.59M (-22.64%) | -58.93M (+10.52%) | -53.32M (-14.01%) | -62.01M (+2.26%) | -60.64M (+15.75%) | -52.39M (+11.37%) | -47.04M (-1.34%) | -47.68M (+0.74%) | -47.33M (+12.45%) | -42.09M (+12.54%) | -37.40M (+17.06%) | -31.95M (+7.79%) | -29.64M (+5.07%) | -28.21M (+14.67%) | -24.60M (-9.26%) | -27.11M (+18.38%) | -22.90M (-0.09%) | -22.92M (+20.50%) | -19.02M (+14.17%) | -16.66M (-1.88%) | -16.98M | 11M (-73.72%) | 42M | -13.36M (-15.12%) | -15.74M (+12.27%) | -14.02M |
EBITDA | -21.51M (-7.00%) | -23.13M (-17.01%) | -27.87M (-38.33%) | -45.19M (-22.74%) | -58.49M (+10.76%) | -52.81M (-14.14%) | -61.51M (+2.45%) | -60.04M (+15.73%) | -51.88M (+11.45%) | -46.55M (-1.34%) | -47.18M (+0.53%) | -46.93M (+12.70%) | -41.64M (+12.75%) | -36.93M (+17.42%) | -31.45M (+7.56%) | -29.24M (+5.33%) | -27.76M (+14.62%) | -24.22M (-9.32%) | -26.71M (+18.71%) | -22.50M (-0.27%) | -22.56M (+21.16%) | -18.62M (+13.81%) | -16.36M (-1.92%) | -16.68M | 11M (-73.37%) | 43M | -13.06M (-15.96%) | -15.54M (+10.84%) | -14.02M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 300K (+328.57%) | 70K (-36.36%) | 110K | - | 430K (+186.67%) | 150K (-37.50%) | 240K | - |
Interest Expense | - | 140K (-82.93%) | 820K (+1.23%) | 810K (+1.25%) | 800K (-3.61%) | 830K (-5.68%) | 880K (+1.15%) | 870K (+93.33%) | 450K (+40.63%) | 320K (0.00%) | 320K (0.00%) | 320K (+3.23%) | 310K (-3.13%) | 320K (+6.67%) | 300K (+76.47%) | 170K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | 450K | - | - | -440.00K (+37.50%) | -320.00K (0.00%) | -320.00K (0.00%) | -320.00K (+3.23%) | -310.00K (-3.13%) | -320.00K (+6.67%) | -300.00K (+76.47%) | -170.00K | - | - | - | - | - | 300K (+328.57%) | 70K (-36.36%) | 110K | - | 430K (+186.67%) | 150K (-37.50%) | 240K | - |
Other Non Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -370.00K | 60K | -140.00K | - | -220.00K (+450.00%) | -40.00K (+100.00%) | -20.00K | - |
Net Income | |||||||||||||||||||||||||||||
Net Income From Continuing Operations | -20.04M (-15.01%) | -23.58M (-10.34%) | -26.30M (-39.26%) | -43.30M (-22.91%) | -56.17M (+12.95%) | -49.73M (-13.90%) | -57.76M (+3.42%) | -55.85M (+18.96%) | -46.95M (+14.21%) | -41.11M (-0.92%) | -41.49M (+0.73%) | -41.19M (+9.69%) | -37.55M (+7.10%) | -35.06M (+14.54%) | -30.61M (+3.59%) | -29.55M (+5.16%) | -28.10M (+14.55%) | -24.53M (-9.28%) | -27.04M (+18.44%) | -22.83M (-0.13%) | -22.86M (+20.13%) | -19.03M (+15.12%) | -16.53M (-2.76%) | -17.00M | 11M (-73.84%) | 42M | -13.25M (-14.63%) | -15.52M (+10.70%) | -14.02M |
Net Income | -20.04M (-15.01%) | -23.58M (-10.34%) | -26.30M (-39.26%) | -43.30M (-22.91%) | -56.17M (+12.95%) | -49.73M (-13.90%) | -57.76M (+3.42%) | -55.85M (+18.96%) | -46.95M (+14.21%) | -41.11M (-0.92%) | -41.49M (+0.73%) | -41.19M (+9.69%) | -37.55M (+7.10%) | -35.06M (+14.54%) | -30.61M (+3.59%) | -29.55M (+5.16%) | -28.10M (+14.55%) | -24.53M (-9.28%) | -27.04M (+18.44%) | -22.83M (-0.13%) | -22.86M (+20.13%) | -19.03M (+15.12%) | -16.53M (-2.76%) | -17.00M | 11M (-73.84%) | 42M | -13.25M (-14.63%) | -15.52M (+10.70%) | -14.02M |
Comprehensive Income Net Of Tax | -20.37M (-86.39%) | -149.68M (+469.78%) | -26.27M (-39.55%) | -43.46M (-22.85%) | -56.33M (-73.22%) | -210.33M (+273.59%) | -56.30M (+0.57%) | -55.98M (+17.14%) | -47.79M (-69.95%) | -159.03M (+286.46%) | -41.15M (-2.26%) | -42.10M (+14.03%) | -36.92M (-70.48%) | -125.08M (+293.21%) | -31.81M (+6.57%) | -29.85M (+3.47%) | -28.85M (-70.39%) | -97.43M (+260.18%) | -27.05M (+18.43%) | -22.84M (0.00%) | -22.84M (-45.04%) | -41.56M (+151.57%) | -16.52M (-3.34%) | -17.09M | 11M | -630.00K (-95.25%) | -13.26M (-14.51%) | -15.51M | - |